These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 37356)

  • 1. Effects of d,l-propranolol and other beta adrenergic receptor blocking agents on membrane fluidity of erythrocytes.
    Akiyama S; Igisu H
    Jpn J Pharmacol; 1979 Feb; 29(1):144-6. PubMed ID: 37356
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonspecific membrane effects of CH-103: hydrophobicity, surface activity and membrane fluidity studies in comparison with propranolol and practolol.
    Varga E; Szöllösi J; Antal K; Kovács P; Szabó JZ
    Pharmazie; 1999 May; 54(5):380-4. PubMed ID: 10368833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol-induced alterations in rat erythrocyte membrane fluidity and apparent phase-transition temperatures. A depth-dependent process.
    Weitman SD; Phelan AM; Lech JJ; Lange DG
    Biochem Pharmacol; 1989 Sep; 38(18):2949-55. PubMed ID: 2783151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of insulin on human erythrocyte membrane fluidity in diabetes mellitus.
    Bryszewska M; Leyko W
    Diabetologia; 1983 May; 24(5):311-3. PubMed ID: 6347778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in erythrocyte membrane fluidity by phenylhydrazine-induced peroxidation of lipids.
    Rice-Evans C; Hochstein P
    Biochem Biophys Res Commun; 1981 Jun; 100(4):1537-42. PubMed ID: 7295314
    [No Abstract]   [Full Text] [Related]  

  • 6. Promotion of membrane resealing by local anesthetics.
    Johnson RT
    Biochem Pharmacol; 1982 May; 31(9):1784-7. PubMed ID: 7104041
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo and in vitro influence of etretinate on erythrocyte membrane fluidity.
    Górnicki A; Gutsze A
    Eur J Pharmacol; 2001 Jul; 423(2-3):127-34. PubMed ID: 11448476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced adenylate cyclase activity of turkey erythrocytes following treatment with beta-adrenergic receptor antagonists.
    Peters JR; Nambi P; Sibley DR; Lefkowitz RJ
    Eur J Pharmacol; 1984 Dec; 107(1):43-52. PubMed ID: 6151904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective estrogen receptor modulator, tamoxifen, and membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women: an electron paramagnetic resonance investigation.
    Tsuda K; Nishio I
    Am J Hypertens; 2005 Aug; 18(8):1067-76. PubMed ID: 16109320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta-adrenergic reactivity in patients with myocardial infarct according to the antihemolytic test].
    Sominskiĭ VN; Anshelevich IuV; Okun' KV
    Kardiologiia; 1990 May; 30(5):24-8. PubMed ID: 1975281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A spin label study on fluidization of human red cell membrane by esters of p-hydroxybenzoic acid: structure-functional aspects on membrane glucose transport.
    Zimmer G; Lacko L; Krüger E
    Biochem Pharmacol; 1981 Aug; 30(16):2362-4. PubMed ID: 7295347
    [No Abstract]   [Full Text] [Related]  

  • 12. Membrane effects of beta-adrenergic blocking agents: investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities.
    Wiethold G; Hellenbrecht D; Lemmer B; Palm D
    Biochem Pharmacol; 1973 Jun; 22(12):1437-49. PubMed ID: 4147326
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of membrane stabilizing drugs affecting human erythrocytes in vitro.
    Olaisen B; Oye I
    Eur J Pharmacol; 1973 Apr; 22(1):112-6. PubMed ID: 4145254
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemolysis of erythrocytes and erythrocyte membrane fluidity changes by new lysosomotropic compounds.
    Kleszczyńska H; Bonarska D; Luczyński J; Witek S; Sarapuk J
    J Fluoresc; 2005 Mar; 15(2):137-41. PubMed ID: 15883768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solanum Nigrum polysaccharide (SNL) extract effects in transplanted tumor-bearing mice--erythrocyte membrane fluidity and blocking of functions.
    Yuan HL; Liu XL; Liu YJ
    Asian Pac J Cancer Prev; 2014; 15(23):10469-73. PubMed ID: 25556494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin effect in vitro on human erythrocyte plasma membrane.
    Luly P; Baldini P; Incerpi S; Tria E
    Experientia; 1981 Apr; 37(4):431-3. PubMed ID: 6113162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triphosphoinositide increases glycoprotein lateral mobility in erythrocyte membranes.
    Sheetz MP; Febbroriello P; Koppel DE
    Nature; 1982 Mar; 296(5852):91-3. PubMed ID: 6278314
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of the concanavalin A-induced change of membrane fluidity of chicken erythrocytes.
    Nakajima M; Tamura E; Irimura T; Toyoshima S; Hirano H; Osawa T
    J Biochem; 1981 Feb; 89(2):665-75. PubMed ID: 7240135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of saikosaponins on biological membranes. 2. Changes in electron spin resonance spectra from spin-labelled erythrocyte and erythrocyte ghost membranes.
    Abe H; Odashima S; Arichi S
    Planta Med; 1978 Nov; 34(3):287-90. PubMed ID: 212771
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissociation between local anesthetic and membrane-stabilizing actions in antiarrhythmic beta-adrenergic blockers and local anesthetics.
    Yasuhara H; Sakamoto K; Ueda I
    Anesth Analg; 1981 Dec; 60(12):897-900. PubMed ID: 6119048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.